Molecular weight (DA)
76kD
Immunogen
Synthesized peptide derived from human protein . at AA range: 180-260
Specificity
NUFP2 Polyclonal Antibody detects endogenous levels of protein.
Formulation
Liquid in PBS containing 50% glycerol, and 0.02% sodium azide.
Dilution rate
WB 1:500-2000 ELISA 1:5000-20000
Purification process (Immunogen)
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Background
function:Binds RNA.,PTM:Phosphorylated upon DNA damage, probably by ATM or ATR.,subcellular location:Distribution is cell cycle-modulated, being cytoplasmic in the G2/M phase and accumulating in nucleus during the G1 phase.,subunit:Interacts with FMRP.,
Function
function:Binds RNA.,PTM:Phosphorylated upon DNA damage, probably by ATM or ATR.,subcellular location:Distribution is cell cycle-modulated, being cytoplasmic in the G2/M phase and accumulating in nucleus during the G1 phase.,subunit:Interacts with FMRP.,
Gene Name
NUFIP2 KIAA1321 PIG1
Protein name
Nuclear fragile X mental retardation-interacting protein 2 (82 kDa FMRP-interacting protein) (82-FIP) (Cell proliferation-inducing gene 1 protein) (FMRP-interacting protein 2)
Human protein sequence Database
Q7Z417
Mouse protein sequence database
Q5F2E7
Rat protein sequence database
Cellular localization
Nucleus . Cytoplasm . Cytoplasm, Stress granule . Distribution is cell cycle-modulated, being cytoplasmic in the G2/M phase and accumulating in nucleus during the G1 phase (PubMed:12837692). .
Tissue expression
Brain,Cervix carcinoma,Epithelium,PCR rescued clones,T-cell,Uterus,